Pediatr. praxi 2018; 19(4): 226-231 | DOI: 10.36290/ped.2018.080

Benefit of the imaging methods in a diagnosis of kaposiform hemangioendothelioma

prof. MUDr. Vladimír Mihál, CSc.1,2, MUDr. Lenka Bakaj‑Zbrožková, Ph.D.3, MUDr. Tomáš Tichý, Ph.D.4, MUDr. Daniel Stehlík5, MUDr. Kamila Michálková3
1 Ústav molekulární a translační medicíny LF UP Olomouc
2 Dětská klinika LF UP a FN v Olomouci
3 Radiologická klinika LF UP a FN v Olomouci
4 Ústav patologie LF UP a FN v Olomouci
5 Oddělení plastické chirurgie LF UP a FN v Olomouci

Kaposiform hemangioendothelioma (KHE) is a rare, aggressive vascular tumor that typically occurs during infancy or early childhood.KHEs grow in various locations and generally exhibit extensive heterogenity. They are characterized by highly infiltrativeand locally invasive clinical properties with ill-defined margins. The imaging methods used in our case-report demonstrated theirbenefit in a difficult diagnostic process.

Keywords: Kaposiform hemangioendothelioma, vascular tumors, child

Received: February 11, 2016; Accepted: February 22, 2018; Prepublished online: April 17, 2018; Published: September 1, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Mihál V, Bakaj‑Zbrožková L, Tichý T, Stehlík D, Michálková K. Benefit of the imaging methods in a diagnosis of kaposiform hemangioendothelioma. Pediatr. praxi. 2018;19(4):226-231. doi: 10.36290/ped.2018.080.
Download citation

References

  1. Zukerberg LR, Nickoloff BJ, Weiss SW. Kaposiform hemangioendothelioma of infancy and childhood. An aggressive neoplasm associated with Kasabach-Merritt syndrome and lymphangiomatosis. Am J Surg Pathol 1993; 17(4): 321-328. Go to original source... Go to PubMed...
  2. Liu Q, Jiang L, Wu D, et al. Clinicopathological features of kaposiform hemangioendothelioma. Int J Clin Exp Pathol. 2015 Oct 1; 8(10): 13711-1378.
  3. Ekfors TO, Kujari H, Herva R. Kaposi-like infantile hemagioepithelioma. Am J Surg Pathol 1993; 17(3): 314-317. Go to original source... Go to PubMed...
  4. Lyons LL, North PE, Mac-Moune Lai F, et al. Kaposiform hemangioendothelioma: a study of 33 cases emphasizing its pathologic, immunophenotypic, and biologic uniqueness from juvenile hemangioma. Am J Surg Pathol 2004; 28(5): 559-568. Go to original source... Go to PubMed...
  5. Mulliken JB, Anupindi S, Ezekowitz RA, Mihm MC Jr. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 13-2004. A newborn girl with a large cutaneous lesion, thrombocytopenia, and anemia. N Engl J Med 2004; 350(17): 1764-1775. Go to original source... Go to PubMed...
  6. Wang Z, Li K, Yao W, et al. Successful treatment of kaposiform lymphangiomatosis with sirolimus. Pediatr Blood Cancer 2015; 62(7): 1291-1293. Go to original source... Go to PubMed...
  7. Malhotra Y, Yang CS, McNamara J, Antaya RJ. Congenital kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon successfully treated with low-dose radiation therapy. Pediatr Dermatol 2014; 31(5): 595-598. Go to original source... Go to PubMed...
  8. Adams D, Frieden IJ, Levy ML. Tufted angioma, kaposiform hemangioendothelioma, and the Kasabach-Merritt phenomenon. In: UpToDate, Post TW (Ed), UpToDate, Waltham, MA. (Accessed on July 27, 2018).
  9. Ryu YJ, Kim WS, Choi YH, et al. Imaging findings of kaposiform hemangioendothelioma in children. AJR Am J Roentgenol. 2015 Dec; 205(6): 1315-1321. Go to PubMed...
  10. Chiu YE, Drolet BA, Blei F, et al. Variable Response to Propranolol Treatment of Kaposiform Hemangioendothelioma, Tufted Angioma, and Kasabach-Merritt Phenomenon Pediatr Blood Cancer. 2012 Nov; 59(5): 934-938. Go to original source... Go to PubMed...




Pediatrics for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.